Duality of statin action on lipoprotein subpopulations in the mixed dyslipidemia of metabolic syndrome: Quantity vs quality over time and implication of CETP.

Autor: Chapman, M. John, Orsoni, Alexina, Robillard, Paul, Therond, Patrice, Giral, Philippe
Předmět:
Zdroj: Journal of Clinical Lipidology; May2018, Vol. 12 Issue 3, p784-800.e4, 1p
Abstrakt: Background Statins impact the metabolism, concentrations, composition, and function of circulating lipoproteins. Objective We evaluated time course relationships between statin-mediated reduction in atherogenic apolipoprotein B (ApoB)–containing particles and dynamic intravascular remodeling of ApoAI-containing lipoprotein subpopulations in the mixed dyslipidemia of metabolic syndrome. Methods Insulin-resistant, hypertriglyceridemic, hypercholesterolemic, obese males (n = 12) were treated with pitavastatin (4 mg/d) and response evaluated at 6, 42, and 180 days. Results Reduction in low-density lipoprotein (LDL) cholesterol, ApoB, and triglycerides (TGs) was essentially complete at 42 days (–38%, –32%, and –35%, respectively); rapid reduction equally occurred in remnant cholesterol, ApoCII, CIII, and E levels (day 6; –35%, –50%, –23%, and –26%, respectively). Small dense LDLs (LDL4 and LDL5 subpopulations) predominated at baseline and were markedly reduced on treatment (–29% vs total LDL mass). Cholesteryl ester (CE) transfer protein activity and mass decreased progressively (–18% and –16%, respectively); concomitantly, TG depletion (up to –49%) and CE enrichment occurred in all high-density lipoprotein (HDL) particle subpopulations with normalization of CE/TG mass ratio at 180 days. ApoAI was redistributed from LpAI to LpAI:AII particles in HDL2a and HDL3a subpopulations; ApoCIII was preferentially depleted from LpAI:AII–rich particles on treatment. Conclusion Overall, statin action exhibits duality in mixed dyslipidemia, as CE transfer protein–mediated normalization of the HDL CE/TG core lags markedly behind subacute reduction in elevated levels of atherogenic ApoB-containing lipoproteins. Normalization of the HDL neutral lipid core is consistent with enhanced atheroprotective function. The HDL CE/TG ratio constitutes a metabolomic marker of perturbed HDL metabolism in insulin-resistant states, equally allowing monitoring of statin impact on HDL metabolism, structure, and function. [ABSTRACT FROM AUTHOR]
Databáze: Supplemental Index
Externí odkaz: